| Dr Jill Marie Steinle, MD | |
|
401 N 9th St, Bismarck, ND 58501-4530 | |
| (701) 530-5952 | |
| Not Available |
| Full Name | Dr Jill Marie Steinle |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 401 N 9th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437314473 | NPI | - | NPPES |
| 17123 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 12396 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
News Archive
Researchers trying to tease out the genetic basis of dyslexia have discovered a location on chromosome 2 that may contain one or more genes that contribute to the reading disorder and make it difficult for people to rapidly pronounce pseudowords.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
Long associated with a worse outcome, researchers at The University of Texas MD Anderson Cancer Center have discovered that women treated for breast cancer while pregnant, in fact, have improved disease free survival and a trend for improved overall survival compared to non-pregnant women treated for the disease.
According to the National Highway Traffic and Safety Administration, from 2004 through 2013, 1,344 people died in school transportation-related crashes—an average of 134 fatalities per year.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
› Verified 6 days ago
| Entity Name | Mid Dakota Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
Researchers trying to tease out the genetic basis of dyslexia have discovered a location on chromosome 2 that may contain one or more genes that contribute to the reading disorder and make it difficult for people to rapidly pronounce pseudowords.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
Long associated with a worse outcome, researchers at The University of Texas MD Anderson Cancer Center have discovered that women treated for breast cancer while pregnant, in fact, have improved disease free survival and a trend for improved overall survival compared to non-pregnant women treated for the disease.
According to the National Highway Traffic and Safety Administration, from 2004 through 2013, 1,344 people died in school transportation-related crashes—an average of 134 fatalities per year.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
› Verified 6 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
Researchers trying to tease out the genetic basis of dyslexia have discovered a location on chromosome 2 that may contain one or more genes that contribute to the reading disorder and make it difficult for people to rapidly pronounce pseudowords.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
Long associated with a worse outcome, researchers at The University of Texas MD Anderson Cancer Center have discovered that women treated for breast cancer while pregnant, in fact, have improved disease free survival and a trend for improved overall survival compared to non-pregnant women treated for the disease.
According to the National Highway Traffic and Safety Administration, from 2004 through 2013, 1,344 people died in school transportation-related crashes—an average of 134 fatalities per year.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jill Marie Steinle, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 530-5952 | Dr Jill Marie Steinle, MD 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 530-5952 |
News Archive
Researchers trying to tease out the genetic basis of dyslexia have discovered a location on chromosome 2 that may contain one or more genes that contribute to the reading disorder and make it difficult for people to rapidly pronounce pseudowords.
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
Long associated with a worse outcome, researchers at The University of Texas MD Anderson Cancer Center have discovered that women treated for breast cancer while pregnant, in fact, have improved disease free survival and a trend for improved overall survival compared to non-pregnant women treated for the disease.
According to the National Highway Traffic and Safety Administration, from 2004 through 2013, 1,344 people died in school transportation-related crashes—an average of 134 fatalities per year.
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
› Verified 6 days ago
Rachel Marohl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4500 | |
Dr. Jessica D Sedevie, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-5441 | |
Dr. Jerry M Obritsch, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4500 Fax: 701-712-4098 | |
Dr. Peter L Klemin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N. 7th St., Medcenter One, Inc., Bismarck, ND 58501 Phone: 701-323-5870 Fax: 701-323-5869 | |
Peter A.u. Woodrow, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-6543 Fax: 701-323-5709 | |
Laura Elizabeth Knutson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4541 Fax: 701-712-4191 | |
Dr. Shannon S Bradley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 |